Buy & Sell KKR & Co Inc (KKR) – KKR & Co Inc Price Today
Aura AI Summary
Key Stats
- $87.07BMarket Cap
- FinancialsSector
- -17.1%3M Drawdown
- $12.59BEnterprise Value
- 0.77%Dividend Yield
- 57 daysTypical Hold Time
KKR & Co Inc (KKR) is currently valued at a market capitalization of $87.07B, with an enterprise value of $12.59B. Over the past 52 weeks, KKR & Co Inc has traded between a low of $83.88 and a high of $152.16, highlighting its annual price range. Over the past three months, KKR & Co Inc has recorded a drawdown of -17.1%, reflecting recent price volatility. KKR & Co Inc offers a dividend yield of 0.77%, with the most recent dividend of $0.20 paid on 15 May 26. On average, investors hold KKR & Co Inc for approximately 57 days, indicating typical investor behavior on the platform.
About KKR & Co Inc
KKR is one of the world's largest alternative asset managers, with $490.7 billion in total assets under management, including $384.5 billion in fee-earning AUM, at the end of June 2022. The company has two core segments: asset management (which includes private markets--private equity, credit, infrastructure, energy and real estate--and public markets--primarily credit and hedge/investment fund platforms) and insurance (following the February 2021 purchase of a 61.5% economic stake in Global Atlantic Financial Group, which is engaged in retirement/annuity and life insurance lines as well as reinsurance). On the asset management side, private markets account for 50% of fee-earning AUM and 70% of base management fees, while public markets account for 50% and 30%, respectively.
Most Recent News
Hedge funds boost semiconductor bets as SOXX ETF exposure hits record highs in Q1 2026
In the first quarter of 2026, hedge funds dramatically increased their investments in semiconductor stocks, pushing sector exposure to a record 19% of global hedge fund portfolios, more than doubling since the start of the year. Major investors like ...
Onconetix shares jump 23.65% after clinical study boosts confidence in prostate cancer test Proclarix.
Onconetix Inc. stock surged 23.65% in after-hours trading following positive clinical validation of its prostate cancer blood test, Proclarix. Two new peer-reviewed studies from Denmark showed Proclarix can reduce unnecessary biopsies and overdiagnos...
Utilities ETF up 1.65% in quarter, driven by data center growth and renewables partnerships.
The Virtus Reaves Utilities ETF rose 1.65% in the quarter but lagged the S&P 500 Utilities Index, while delivering a 25.49% return over the past year. Key utilities like Entergy and Meta expanded their power generation commitments by 5 gigawatts to s...